The HIV-1 Tat protein has a versatile role in activating viral transcription

Journal of Virology

Volumn 85, Issue 18, 2011, Pages 9506-9516

  Das, Atze T ^a   Harwig, Alex ^a   Berkhout, Ben ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TAR; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION SYSTEM; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LYMPHOCYTE CULTURE; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TRANSACTIVATION; TRANSCRIPTION INITIATION; VIRUS GENE; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

CELL LINE; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; PROMOTER REGIONS, GENETIC; RNA, VIRAL; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TRANSCRIPTION, GENETIC; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 80052452885     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00650-11     Document Type: Article

References (81)

1. Amendt, B. A., D. Hesslein, L.-J. Chang, and C. M. Stoltzfus. 1994. Presence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1. Mol. Cell. Biol. 14:3960-3970.
2. Amendt, B. A., Z.-H. Si, and C. M. Stoltzfus. 1995. Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors. Mol. Cell. Biol. 15:4606-4615.
3. Apolloni, A., L. W. Meredith, A. Suhrbier, R. Kiernan, and D. Harrich. 2007. The HIV-1 Tat protein stimulates reverse transcription in vitro. Curr. HIV Res. 5:473-483.
4. Bagasra, O., K. Khalili, T. Seshamma, J. P. Taylor, and R. J. Pomerantz. 1992. TAR-independent replication of human immunodeficiency virus type 1 in glial cells. J. Virol. 66:7522-7528.
5. Bannwarth, S., and A. Gatignol. 2005. HIV-1 TAR RNA: the target of molecular interactions between the virus and its host. Curr. HIV Res. 3: 61-71.
6. Bennasser, Y., and K. T. Jeang. 2006. HIV-1 Tat interaction with Dicer: requirement for RNA. Retrovirology 3:95.
7. Bennasser, Y., S. Y. Le, M. Benkirane, and K. T. Jeang. 2005. Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Immunity 22:607-619.
8. Berkhout, B., A. T. Das, and N. Beerens. 2001. HIV-1 RNA editing, hypermutation and error-prone reverse transcription. Science 292:7.
9. Berkhout, B. 2009. A new Houdini act: multiple routes for HIV-1 escape from RNAi-mediated inhibition. Future Microbiol. 4:151-154.
10. Berkhout, B., and A. de Ronde. 2004. APOBEC3G versus reverse transcriptase in the generation of HIV-1 drug-resistance mutations. AIDS 18:1861- 1863.
11. Berkhout, B., A. Gatignol, A. B. Rabson, and K. T. Jeang. 1990. TARindependent activation of the HIV-1 LTR: evidence that Tat requires specific regions of the promoter. Cell 62:757-767.
12. Berkhout, B., and K. T. Jeang. 1992. Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat. J. Virol. 66:139-149.
13. Berkhout, B., K. Verhoef, J. L. van Wamel, and N. K. Back. 1999. Genetic instability of live, attenuated human immunodeficiency virus type 1 vaccine strains. J. Virol. 73:1138-1145.
14. Bieniasz, P. D., T. A. Grdina, H. P. Bogerd, and B. R. Cullen. 1999. Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription. Proc. Natl. Acad. Sci. U. S. A. 96:7791-7796.
15. Braddock, M., R. Powell, A. D. Blanchard, A. J. Kingsman, and S. M. Kingsman. 1993. HIV-1 TAR RNA-binding proteins control TAT activation of translation in Xenopus oocytes. FASEB J. 7:214-222.
16. Braddock, M., et al. 1990. A nuclear translational block imposed by the HIV-1 U3 region is relieved by the Tat-TAR interaction. Cell 62:1123-1133.
17. Brady, J., and F. Kashanchi. 2005. Tat gets the "green" light on transcription initiation. Retrovirology 2:69.
18. Charnay, N., et al. 2009. Mechanism of HIV-1 Tat RNA translation and its activation by the Tat protein. Retrovirology 6:74.
19. Chiu, Y. L., E. Coronel, C. K. Ho, S. Shuman, and T. M. Rana. 2001. HIV-1 Tat protein interacts with mammalian capping enzyme and stimulates capping of TAR RNA. J. Biol. Chem. 276:12959-12966.
20. Chiu, Y. L., et al. 2002. Tat stimulates cotranscriptional capping of HIV mRNA. Mol. Cell 10:585-597.
21. Chun, R. F., O. J. Semmes, C. Neuveut, and K.-T. Jeang. 1998. Modulation of Sp1 phosphorylation by human immunodeficiency virus type 1 Tat. J. Virol. 72:2615-2629.
22. Das, A. T., A. Harwig, M. M. Vrolijk, and B. Berkhout. 2007. The TAR hairpin of human immunodeficiency virus type 1 can be deleted when not required for Tat-mediated activation of transcription. J. Virol. 81:7742-7748.
23. Das, A. T., B. Klaver, and B. Berkhout. 1998. The 5′ and 3′ TAR elements of the human immunodeficiency virus exert effects at several points in the virus life cycle. J. Virol. 72:9217-9223.
24. Das, A. T., B. Klaver, and B. Berkhout. 1999. A hairpin structure in the R region of the human immunodeficiency virus type 1 RNA genome is instrumental in polyadenylation site selection. J. Virol. 73:81-91.
25. Das, A. T., et al. 2008. Optimization of the doxycycline-dependent simian immunodeficiency virus through in vitro evolution. Retrovirology 5:44.
26. Das, A. T., et al. 2007. Construction of a doxycycline-dependent simian immunodeficiency virus reveals a nontranscriptional function of Tat in viral replication. J. Virol. 81:11159-11169.
27. Das, A. T., B. Klaver, B. I. F. Klasens, J. L. B. van Wamel, and B. Berkhout. 1997. A conserved hairpin motif in the R-U5 region of the human immunodeficiency virus type 1 RNA genome is essential for replication. J. Virol. 71:2346-2356.
28. Das, A. T., K. Verhoef, and B. Berkhout. 2004. A conditionally replicating virus as a novel approach toward an HIV vaccine. Methods Enzymol. 388: 359-379.
29. Das, A. T., et al. 2004. Viral evolution as a tool to improve the tetracyclineregulated gene expression system. J. Biol. Chem. 279:18776-18782.
30. Easley, R., et al. 2010. Chromatin dynamics associated with HIV-1 Tatactivated transcription. Biochim. Biophys. Acta 1799:275-285.
31. Gatignol, A. 2007. Transcription of HIV: Tat and cellular chromatin. Adv. Pharmacol. 55:137-159.
32. Gautier, V. W., et al. 2009. In vitro nuclear interactome of the HIV-1 Tat protein. Retrovirology 6:47.
33. Haasnoot, J., et al. 2007. The Ebola virus VP35 protein is a suppressor of RNA silencing. PLoS Pathog. 3:e86.
34. Harrich, D., J. Garcia, R. Mitsuyasu, and R. Gaynor. 1990. TAR independent activation of the human immunodeficiency virus in phorbol ester stimulated T lymphocytes. EMBO J. 9:4417-4423.
35. Harrich, D., et al. 1989. Role of Sp1-binding domains in in vivo transcrip-tional regulation of the human immunodeficiency virus type 1 long terminal repeat. J. Virol. 63:2585-2591.
36. Harrich, D., C. Ulich, L. F. Garcia-Martinez, and R. B. Gaynor. 1997. Tat is required for efficient HIV-1 reverse transcription. EMBO J. 16:1224-1235.
37. Huang, L. M., A. Joshi, R. Willey, J. Orenstein, and K. T. Jeang. 1994. Human immunodeficiency viruses regulated by alternative trans-activators: genetic evidence for a novel non-transcriptional function of Tat in virion infectivity. EMBO J. 13:2886-2896.
38. Jablonski, J. A., A. L. Amelio, M. Giacca, and M. Caputi. 2010. The transcriptional transactivator Tat selectively regulates viral splicing. Nucleic Acids Res. 38:1249-1260.
39. Jacquenet, S., et al. 2001. A second exon splicing silencer within human immunodeficiency virus type 1 tat exon 2 represses splicing of tat mRNA and binds protein hnRNP H. J. Biol. Chem. 276:40464-40475.
40. Jeang, K. T., et al. 1993. In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor. J. Virol. 67:6224-6233.
41. Jeeninga, R. E., et al. 2000. Functional differences between the long terminal repeat transcriptional promoters of HIV-1 subtypes A through G. J. Virol. 74:3740-3751.
42. Jeeninga, R. E., B. Jan, H. van den Berg, and B. Berkhout. 2006. Construction of doxycycline-dependent mini-HIV-1 variants for the development of a virotherapy against leukemias. Retrovirology 3:64.
43. Kameoka, M., et al. 2002. The Tat protein of human immunodeficiency virus type 1 (HIV-1) can promote placement of tRNA primer onto viral RNA and suppress later DNA polymerization in HIV-1 reverse transcription. J. Virol. 76:3637-3645.
44. Kameoka, M., L. Rong, M. Götte, C. Liang, R. S. Russell, and M. A. Wainberg. 2001. Role for human immunodeficiency virus type 1 Tat protein in suppression of viral reverse transcriptase activity during late stages of viral replication. J. Virol. 75:2675-2683.
45. Kamine, J., and G. Chinnadurai. 1992. Synergistic activation of the human immunodeficiency virus type 1 promoter by the viral Tat protein and cellular transcription factor Sp1. J. Virol. 66:3932-3936.
46. Kammler, S., et al. 2006. The strength of the HIV-1 3′ splice sites affects Rev function. Retrovirology 3:89-108.
47. Klasens, B. I. F., M. Thiesen, A. Virtanen, and B. Berkhout. 1999. The ability of the HIV-1 AAUAAA signal to bind polyadenylation factors is controlled by local RNA structure. Nucleic Acids Res. 27:446-454.
48. Koken, S. E. C., J. L. van Wamel, J. Goudsmit, B. Berkhout, and J. L. Geelen. 1992. Natural variants of the HIV-1 long terminal repeat: analysis of promoters with duplicated DNA regulatory motifs. Virology 191:968-972.
49. Kozak, M. 1989. Context effects and inefficient initiation at non-AUG codons in eucaryotic cell-free translation systems. Mol. Cell. Biol. 9:5073-5080.
50. Leonard, J. N., P. S. Shah, J. C. Burnett, and D. V. Schaffer. 2008. HIV evades RNA interference directed at TAR by an indirect compensatory mechanism. Cell Host Microbe 4:484-494.
51. Lin, J., and B. R. Cullen. 2007. Analysis of the interaction of primate retroviruses with the human RNA interference machinery. J. Virol. 81: 12218-12226.
52. Loregian, A., K. Bortolozzo, S. Boso, A. Caputo, and G. Palu. 2003. Interaction of Sp1 transcription factor with HIV-1 Tat protein: looking for cellular partners. FEBS Lett. 543:61-65.
53. Loregian, A., et al. 2003. The Sp1 transcription factor does not directly interact with the HIV-1 Tat protein. J. Cell. Physiol. 196:251-257.
54. Marzio, G., K. Verhoef, M. Vink, and B. Berkhout. 2001. In vitro evolution of a highly replicating, doxycycline-dependent HIV for applications in vaccine studies. Proc. Natl. Acad. Sci. U. S. A. 98:6342-6347.
55. Marzio, G., M. Vink, K. Verhoef, A. de Ronde, and B. Berkhout. 2002. Efficient human immunodeficiency virus replication requires a fine-tuned level of transcription. J. Virol. 76:3084-3088.
56. Mikaelian, I., and A. Sergeant. 1992. A general and fast method to generate multiple site directed mutations. Nucleic Acids Res. 20:376.
57. Pagtakhan, A. S., and S. E. Tong-Starksen. 1997. Interactions between Tat of HIV-2 and transcription factor Sp1. Virology 238:221-230.
58. Parada, C. A., and R. G. Roeder. 1996. Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain. Nature 384:375-378.
59. Peden, K., M. Emerman, and L. Montagnier. 1991. Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI. Virology 185:661-672.
60. Pisarev, A. V., et al. 2006. Specific functional interactions of nucleotides at key -3 and +4 positions flanking the initiation codon with components of the mammalian 48S translation initiation complex. Genes Dev. 20:624-636.
61. Raha, T., S. W. Cheng, and M. R. Green. 2005. HIV-1 Tat stimulates transcription complex assembly through recruitment of TBP in the absence of TAFs. PLoS Biol. 3:e44.
62. Richter, S., Y. H. Ping, and T. M. Rana. 2002. TAR RNA loop: a scaffold for the assembly of a regulatory switch in HIV replication. Proc. Natl. Acad. Sci. U. S. A. 99:7928-7933.
63. Romani, B., S. Engelbrecht, and R. H. Glashoff. 2010. Functions of Tat: the versatile protein of human immunodeficiency virus type 1. J. Gen. Virol. 91:1-12.
64. Ruijter, J. M., et al. 2006. Factor correction as a tool to eliminate betweensession variation in replicate experiments: application to molecular biology and retrovirology. Retrovirology 3:2.
65. Salter, R. D., D. N. Howell, and P. Cresswell. 1985. Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids. Immunogenetics 21: 235-246.
66. Sanghvi, V. R., and L. F. Steel. 2011. A re-examination of global suppression of RNA interference by HIV-1. PLoS One 6:e17246.
67. Schnettler, E., et al. 2009. The NS3 protein of rice hoja blanca virus complements the RNAi suppressor function of HIV-1 Tat. EMBO Rep. 10:258-263.
68. SenGupta, D. N., B. Berkhout, A. Gatignol, A. M. Zhou, and R. H. Silverman. 1990. Direct evidence for translational regulation by leader RNA and Tat protein of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. U. S. A. 87:7492-7496.
69. Si, Z., B. A. Amendt, and C. M. Stoltzfus. 1997. Splicing efficiency of human immunodeficiency virus type 1 tat RNA is determined by both a suboptimal 3′ splice site and a 10 nucleotide exon splicing silencer element located within tat exon 2. Nucleic Acids Res. 25:861-867.
70. Smith, S. D., et al. 1984. Monoclonal antibody and enzymatic profiles of human malignant T- lymphoid cells and derived cell lines. Cancer Res. 44:5657-5660.
71. Smith, S. M., M. Khoroshev, P. A. Marx, J. Orenstein, and K. T. Jeang. 2001. Constitutively dead, conditionally live HIV-1 genomes. Ex vivo implications for a live virus vaccine. J. Biol. Chem. 276:32184-32190.
72. Tan, R., A. Brodsky, J. R. Williamson, and A. D. Frankel. 1997. RNA recognition by HIV-1 Tat and Rev. Semin. Virol. 8:186-193.
73. Taylor, J. P., et al. 1992. TAR-independent transactivation by Tat in cells derived from the CNS: a novel mechanism of HIV-1 gene regulation. EMBO J. 11:3395-3403.
74. Verhoef, K., M. Koper, and B. Berkhout. 1997. Determination of the minimal amount of Tat activity required for human immunodeficiency virus type 1 replication. Virology 237:228-236.
75. Verhoef, K., G. Marzio, W. Hillen, H. Bujard, and B. Berkhout. 2001. Strict control of human immunodeficiency virus type 1 replication by a genetic switch: Tet for Tat. J. Virol. 75:979-987.
76. Vrolijk, M. M., A. Harwig, B. Berkhout, and A. T. Das. 2009. Destabilization of the TAR hairpin leads to extension of the polyA hairpin and inhibition of HIV-1 polyadenylation. Retrovirology 6:13.
77. Wei, P., M. E. Garber, S.-M. Fang, W. H. Fisher, and K. A. Jones. 1998. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 92:451-462.
78. Yang, L., et al. 1997. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat. Virology 235:48-64.
79. Zahler, A. M., C. K. Damgaard, J. Kjems, and M. Caputi. 2004. SC35 and heterogeneous nuclear ribonucleoprotein A/B proteins bind to a juxtaposed exonic splicing enhancer/exonic splicing silencer element to regulate HIV-1 tat exon 2 splicing. J. Biol. Chem. 279:10077-10084.
80. Zhou, M., et al. 2003. The Tat/TAR-dependent phosphorylation of RNA polymerase II C-terminal domain stimulates cotranscriptional capping of HIV-1 mRNA. Proc. Natl. Acad. Sci. U. S. A. 100:12666-12671.
81. Zuker, M. 2003. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 31:3406-3415.